Please ensure Javascript is enabled for purposes of website accessibility
Teva Pharmaceutical Industries Stock Quote

Teva Pharmaceutical Industries (NYSE: TEVA)

Price as of March 30, 2023, 1:42 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Teva Pharmaceutical Industries Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TEVA +0.34% -48.27% -12.35% +2,076%
S&P -13.04% +52.52% +8.80% +1,601%

Teva Pharmaceutical Industries Company Info

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

News & Analysis

The Fool has written over 900 articles on Teva Pharmaceutical Industries.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/30/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.